Nitric oxide and the vascular endothelium in myocardial ischemia-reperfusion injury

Annals of the New York Academy of Sciences

Volumn 874, Issue , 1999, Pages 354-370

  Vinten Johansen, Jakob ^a,b   Zhao, Zhi Qing ^a   Nakamura, Masanori ^a   Jordan, James E ^a   Ronson, Russell S ^a   Thourani, Vinod H ^a   Guyton, Robert A ^a  

^a Cardiothoracic Research Laboratory   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CELL ADHESION MOLECULE; CITRULLINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE;

CELL ADHESION; CONFERENCE PAPER; CORONARY ARTERY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NEUTROPHIL; REPERFUSION INJURY; VASCULAR ENDOTHELIUM;

EID: 0032809445     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09251.x     Document Type: Conference Paper

References (64)

1. 1. KUBES, P., M. SUZUKI & D.N. GRANGER. 1990. Modulation of PAF-induced leukocyte adherence and increased microvascular permeability. Am. J. Physiol. 259: G859-G864.
2. 2. KUBES, P., M. SUZUKI & N. GRANGER. 1991. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc. Natl. Acad, Sci. USA 88; 4651-4655.
3. 3. MCCALL, T., B.J.R. WHITTLE, N.K. BROUGHTON-SMITH et al. 1988. Inhibition of FMLP-induced aggregation of rabbit neutrophils by nitric oxide. Br. J. Pharmacol, 95: 517P.
4. 4. DREYER, W.J., L.H. MICHAEL, M.W, WEST et al. 1991. Neutrophil accumulation in ischemic canine myocardium: Insights into time course, distribution, and mechanism of localization during early reperfusion. Circulation 84: 400-411.
5. 5. ENTMAN, M.L., L. MICHAEL, R.D. ROSSEN et al. 1991. Inflammation in the course of early myocardial ischemia. FASEB J. 5: 2529-2537.
6. 6. MULLANE, K. 1991. Neutrophil and endothelial changes in reperfusion injury. Trends Cardiovasc. Med. 1: 282-289.
7. 7. MULLANE, K.M., N. READ, J.A. SALMON et al. 1984. Role of leukocytes in acute myocardial infarction in anesthetized dogs: Relationship to myocardial salvage by anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 228: 510-522.
8. 8. LUCCHESI, B.R. 1994. Complement, neutrophils and free radicals: mediators of reperfusion injury. [Review]. Arzneim-Forsch./Drug Res. 44: 420-432.
9. 9. LEFER, A.M. 1995. Role of selectins in myocardial ischemia-reperfusion injury. [Review]. Ann. Thorac. Surg. 60: 773-777.
10. 10. LEFER, A.M., P.S. TSAO, D.J. LEFER et al. 1991. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J. 5: 2029-2034.
11. 11. TSAO, P.S., N. AOKI, D.J. LEFER et al. 1990. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 82: 1402-1412.
12. 12. TSAO, P.S. & A.M. LEFER. 1990. Time course and mechanism of endothelial dysfunction in isolated ischemic-and hypoxic-perfused rat hearts. Am. J. Physiol. 259: H1660-H1666.
13. 13. DIGNAN, R.J., C.M. DYKE, A.S. ABD-ELFATTAH et al. 1992. Coronary artery endothelial cell and smooth muscle dysfunction after global myocardial ischemia. Ann. Thorac. Surg. 53: 311-317.
14. 14. NAKANISHI, K., Z.-Q. ZHAO, J. VINTEN-JOHANSEN et al. 1994. Coronary artery endothelial dysfunction after ischemia, blood cardioplegia, and reperfusion. Ann. Thorac. Surg. 58: 191-199.
15. 15. GUO, J.-P., T. MUROHARA, M. BUERKE et al. 1996. Direct measurement of nitric oxide release from vascular endothelial cells. J. Appl. Physiol. 81: 774-779.
16. 16. ENGELMAN, D.T., M. WATANABE, R.M. ENGLEMAN et al. 1995. Constitutive nitric oxide release is impaired after ischemia and reperfusion. J. Thorac. Cardiovasc. Surg. 110: 1047-1053.
17. 17. MA, X.-L., A.S. WEYRICH, D.J. LEFER et al. 1993. Diminished basal nitric oxide release after myocardial ischemia and repertusion promotes neutrophil adherence to coronary endothelium. Circ. Res. 72: 403-412.
18. 18. LEFER, A.M., X.-L. MA, A. WEYRICH et al. 1993. Endothelial dysfunction and neutrophil adherence as critical events in the development of reperfusion injury. Agents Actions Suppl 41: 127-135.
19. 19. VANBENTHUYSEN, K.M., I.F. MCMURTRY & L.D. HORWITZ. 1987. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J. Clin. Invest. 79: 265-274.
20. 20. NAKANISHI, K., J. VINTEN-JOHANSEN, D.J. LEFER et al. 1992. Intracoronary L-arginine during reperfusion improves endothelial function and reduces infarct size. Am. J. Physiol. 263: H1650-H1658.
21. 21. LEFER, D.J., K. NAKANISHI, J. VINTEN-JOHANSEN et al. 1992. Cardiac venous endothelial dysfunction after myocardial ischemia and reperfusion in dogs. Am. J. Physiol. 263: H850-H856.
22. 22. SOBEY, C.G., G.J. DUSTING, H.J. GROSSMAN et al. 1990. Impaired vasodilation of epicardial coronary arteries and resistance vessels following myocardial ischemia and reperfusion in anesthetized dogs. Cor. Art. Dis. 1: 363-374.
23. 23. KAEFFER, N., V. RICHARD, A. FRANCOIS et al. 1996. Preconditioning prevents chronic reperfusion-induced coronary endothelial dysfunction in rats. Am. J. Physiol. 271: H842-H849.
24. 24. LEFER, D.J., K. NAKANISHI, W.E. JOHNSTOM et al. 1993. Antineutrophil and myocardial protection actions of a novel nitric oxide donor after acute myocardial ischemia and reperfusion in dogs. Circulation 88: 2337-2350.
25. 25. GIRALDEZ R.R., A. PANDA, Y. XIA et al. 1997. Decreased nitric-oxide synthase activity causes impaired endothelium-dependent relaxation in the postischemic heart. J. Biol. Chem. 272: 21420-21426.
26. 26. LORANT, D.E., K.D. PATEL, T.M. MCINTYRE et al. 1991. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J. Cell Biol. 115: 223-234.
27. 27. SLUITER, W., A. PIETERSMA, J.M.J. LAMERS et al. 1993. Leukocyte adhesion molecules on the vascular endothelium: their role in the pathogenesis of cardiovascular disease and the mechanisms underlying their expression. J. Cardiovasc. Pharmacol. 22 (Suppl 4): S37-S44.
28. 28. WEYRICH, A.S., M. BUERKE, K.H. ALBERTINE et al. 1995. Time course of coronary vascular endothelial adhesion molecule expression during reperfusion of the ischemic feline myocardium. J. Leukocyte Biol. 57: 45-55.
29. 29. BIENVENC, K. & D.N. GRANGER. 1993. Molecular determinants of shear-rate dependent leukocyte adhesion in postcapillary venules. Am. J. Physiol. 264: H1504-H1508.
30. 30. GENG, J.-G., M.P. BEVILACQUA, K.L. MOORE et al. 1990. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 343: 757-760.
31. 31. DAVENPECK, K.L., T.W. GAUTHIER, K.H. ALBERTINE et al. 1994. Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. Am. J. Physiol. 267: H622-630.
32. 32. WEYRICH, A.S., X.-L. MA, D.J. LEFER et al. 1993. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91: 2620-2629.
33. 33. JEROME, S.N., M. DORE, J.C. PAULSON et al. 1994. P-selectin and ICAM-1-dependent adherence reactions: role in the genesis of postischemic no-reflow. Am. J. Physiol. 266: H1316-1321.
34. 34. CHEN, L.Y., W.W. NICHOLS, J.B. HENDRICKS et al. 1994. Monoclonal antibody to P-selectin (FB1.3) protects against myocardial reperfusion injury in the dog. Cardiovasc. Res. 28: 1414-1422.
35. 35. KUBES, P., M. JUTILA & D. PAYNE. 1995. Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J. Clin. Invest. 95: 2510-2519.
36. 36. MOORE, K.L., K.D. PATEL, R.E. BRUEHU et al. 1995. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J. Cell Biol. 128: 661-671.
37. 37. BUERKE, M., A.S. WEYRICH, T. MUROHARA et al. 1994. Humanized monoclonal antibody DREG-200 directed against L-selectin protects in feline myocardial reperfusion injury. J. Pharmacol. Exp. Ther. 271: 134-142.
38. 38. MA, X.-L., A.S. WEYRICH, D.J. LEFER et al. 1993. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation 88: 649-658.
39. 39. MA, X.-L., P.S. TSAO & A.M. LEFER. 1991. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion. J. Clin. Invest. 88: 1237-1243.
40. 40. KUKIELKA, G.L., H.K. HAWKINS, L. MICHAEL et al. 1993. Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium. J. Clin. Invest. 92: 1504-1516.
41. 41. YOUKER, K.A., H.K. HAWKINS, G.L. KUKIELKA et al. 1994. Molecular evidence for induction of intracellular adhesion molecule-1 in the viable border zone associated with ischemia-reperfusion injury of the dog heart. Circulation 89: 2736-2746.
42. 42. ZHAO, Z.-Q., D.J. LEFER, H. SATO et al. 1997. Monoclonal antibody to ICAM-1 preserves postischemic blood flow and reduces infarct size after ischemia-reperfusion in rabbit. J. Leukocyte Biol. 62: 292-300.
43. 43. IOCULANO, M., F. SQUADRITO, D. ALTAVILLA et al. 1994. Antibodies against intercellular adhesion molecule 1 protect against myocardial ischaemia-reperfusion injury in rat. Eur. J. Pharmacol. 264: 143-149.
44. 44. DAVENPECK, K.L., T.W. GAUTHIER & A.M. LEFER. 1994. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation [see comments]. Gastroenterology 107: 1050-1058.
45. 45. DECATERINA, R., O. LIBBY, H. PENG et al. 1995. Nitric oxide decreases cytokine-induced endothelial activation. J. Clin. Invest. 96: 60-68.
46. 46. ARMSTEAD, V.E., A.G. MINCHENKO, R.A. SCHUHL et al. 1997. Regulation of P-selectin expression in human endothelial cells by nitric oxide. Am. J. Physiol. Heart Circ Physiol. 42: H740-H746.
47. 47. WOOLFSON, R.G., V.C. PATEL, G.H. NEILD et al. 1995. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 91: 1545-1551.
48. 48. SCHULZ, R., R. WAMBOLT et al. 1995. Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc. Res. 30: 432-439.
49. 49. SUN, W. & C.L. WAINWRIGHT. 1997. The role of nitric oxide in modulating ischaemia-induced arrhythmias in rats. J. Cardiovasc. Pharmacol. 29: 554-562.
50. 50. PABLA, R. & M.J. CURTIS. 1996. Endogenous protection against reperfusion-induced ventricular fibrillation: role of neuronal versus non-neuronal sources of nitric oxide and species dependence in the rat versus rabbit isolated heart. J. Mol. Cell Cardiol. 28: 2097-2110.
51. 51. WILLIAMS, M.W., C.S. TAFT, S. RAMNAUTH et al. 1995. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc. Res. 30: 79-86.
52. 52. PABLA, R. & M.J. CURTIS. 1996. Effect of endogenous nitric oxide on cardiac systolic and diastolic function during ischemia and repcrfusion in the rat isolated perfused heart. J. Mol. Cell Cardiol. 28: 2111-2121.
53. 53. PABLA, R., A.J. BUDA, D.M. FLYNN et al. 1996. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ. Res. 78: 65-72.
54. 54. HOSHIDA, S., N. YAMASHITA, J. IGARASHI et al. 1995. Nitric oxide synthase protects the heart against ischemia-reperfusion injury in rabbits. J. Pharmacol. Exp. Ther. 274: 413-418.
55. 55. PATEL, V.C., R.G. WOOLFSON, G.H. NEILD & D.M. YELLON. 1993. Reduction of infarct size following nitric oxide inhibition is due to compensatory adenosine release. Circulation 88: I-330(Abstract).
56. 56. PATEL, V.C., D.M. YELLON, K.J. SINGH et al. 1993. Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochem. Biophys. Res. Commun. 194: 234-238.
57. 57. PALMER, R.M.J., D.D. REES, D.S. ASHTON et al. 1988. L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153: 1251-1256.
58. 58. WEYRICH, A.S., X.-L. MA & A.M. LEFER. 1992. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86: 279-288.
59. 59. JOHNSON, G., III, P.S. TSAO, D. MULLOY et al. 1990. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J. Pharmacol. Exp. Ther. 252: 35-41.
60. 60. JOHNSON, G., III, P.S. TSAO & A.M. LEFER. 1991. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit. Care Med. 19: 244-252.
61. 61. SIEGFRIED, M.R., J. ERHARDT, T. RIDER et al. 1992. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J. Pharmacol. Exp. Ther. 260: 668-675.
62. 62. LEFER, D.J., K. NAKANISHI & J. VINTEN-JOHANSEN. 1993. Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion. J. Cardiovasc. Pharmacol. 22: S34-S43.
63. 63. DELYANI, J.A., T.O. NOSSULI, R. SCALIA et al. 1996. S-nitrosylated tissue-type plasminogen activator protects against myocardial ischemia/reperfusion injury in cats: role of the endothelium. J. Pharmacol. Exp. Ther. 279: 1174-1180.
64. 64. PABLA, R., A.J. BUDA, D.M. FLYNN et al. 1995. Intracoronary nitric oxide improves postischemic coronary blood flow and myocardial contractile function. Am. J. Physiol. 269: H1113-H1121.